New ways of assessing ovarian cancer response: metabolic imaging and beyond

about

Elastography, a sensitive tool for the evaluation of neoadjuvant chemotherapy in patients with high-grade serous ovarian carcinoma Resistance to the tyrosine kinase inhibitor axitinib is associated with increased glucose metabolism in pancreatic adenocarcinoma.

P2860

Q34141798-F8B05B3E-D66F-45FC-8599-04D3E90AA3B3 Q39005415-83D8623B-F2D6-497C-8869-EEA9FC2F0720

P2860

New ways of assessing ovarian cancer response: metabolic imaging and beyond

Item

http://www.wikidata.org/entity/Q36286480

description

2012 nî lūn-bûn

@nan

2012年の論文

@ja

2012年学术文章

@wuu

2012年学术文章

@zh-cn

2012年学术文章

@zh-hans

2012年学术文章

@zh-my

2012年学术文章

@zh-sg

2012年學術文章

@yue

2012年學術文章

@zh

2012年學術文章

@zh-hant

name

New ways of assessing ovarian cancer response: metabolic imaging and beyond

@ast

New ways of assessing ovarian cancer response: metabolic imaging and beyond

@en

type

Item

label

New ways of assessing ovarian cancer response: metabolic imaging and beyond

@ast

New ways of assessing ovarian cancer response: metabolic imaging and beyond

@en

prefLabel

New ways of assessing ovarian cancer response: metabolic imaging and beyond

@ast

New ways of assessing ovarian cancer response: metabolic imaging and beyond

@en

P1476

New ways of assessing ovarian cancer response: metabolic imaging and beyond

@en

P2093

Alice Munari

http://www.w3.org/2001/XMLSchema#string

Andrea Rockall

http://www.w3.org/2001/XMLSchema#string

Norbert Avril

http://www.w3.org/2001/XMLSchema#string

P2860

Cancer statistics, 2012

New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)

Cancer statistics, 2009

Surveillance of patients after initial treatment of ovarian cancer.

Newly and relapsed epithelial ovarian carcinoma: ESMO clinical recommendations for diagnosis, treatment and follow-up.

Integrated FDG PET/CT in patients with persistent ovarian cancer: correlation with histologic findings.

GLUT-1 expression in ovarian carcinoma: association with survival and response to chemotherapy.

[18F]FDG PET as a substitute for second-look laparotomy in patients with advanced ovarian carcinoma.

Advanced ovarian carcinoma: usefulness of [(18)F]FDG-PET in combination with CT for lesion detection after primary treatment.

Expression of GLUT-1 glucose transfer, cellular proliferation activity and grade of tumor correlate with [F-18]-fluorodeoxyglucose uptake by positron emission tomography in epithelial tumors of the ovary.

P304

310-314

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

review article

P356

10.1102/1470-7330.2012.9004

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2012-09-28T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

231612660

http://www.w3.org/2001/XMLSchema#string

P698

23022953

http://www.w3.org/2001/XMLSchema#string

P921

P932

3460555

http://www.w3.org/2001/XMLSchema#string

New ways of assessing ovarian cancer response: metabolic imaging and beyond

about

P2860

P2860

New ways of assessing ovarian cancer response: metabolic imaging and beyond

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P478

P577

P5875

P698

P921

P932